UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 110

Sortiert nach

Long-Acting Cabotegravir and Rilpivirine for Maintenance of HIV-1 Suppression

The New England journal of medicine, 2020-03, Vol.382 (12), p.1112-1123

2020

Volltextzugriff (PDF)

Wie wirken Generikaquoten? Eine Analyse am Beispiel der HIV-Infektion

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, 2021, Vol.64 (5), p.625-634

2021

Volltextzugriff (PDF)

Häufigkeiten von Patienten mit HIV in der ambulanten Versorgung in Deutschland – Eine Analyse auf Basis von Sekundärdaten

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, 2020, Vol.63 (10), p.1250-1261

2020

Volltextzugriff (PDF)

Long-Acting Injectable Cabotegravir + Rilpivirine for HIV Maintenance Therapy: Week 48 Pooled Analysis of Phase 3 ATLAS and FLAIR Trials

Journal of acquired immune deficiency syndromes (1999), 2020-12, Vol.85 (4), p.498

2020

Volltextzugriff (PDF)

Transmitted drug resistance and subtype patterns of viruses from reported new HIV diagnoses in Germany, 2017–2020

BMC infectious diseases, 2023-10, Vol.23 (1), p.1-673, Article 673

2023

Volltextzugriff (PDF)

Effect of antiviral therapy for HCV on lipid levels

Antiviral therapy, 2017, Vol.21 (1), p.81-88

2017

Volltextzugriff (PDF)

Real‐world effectiveness of sofosbuvir‐based treatment regimens for chronic hepatitis C genotype 3 infection: Results from the multicenter German hepatitis C cohort (GECCO‐03)

Journal of medical virology, 2018-02, Vol.90 (2), p.304-312

2018

Volltextzugriff (PDF)

High effectiveness of recommended first-line antiretroviral therapies in Germany: a nationwide, prospective cohort study

Infection, 2020-06, Vol.48 (3), p.453-461

2020

Volltextzugriff (PDF)

Benefit of Treatment Individualization in Patients with Chronic Hepatitis C Receiving Peginterferon Alfa-2a and Ribavirin in a Large Noninterventional Cohort Study

PloS one, 2015-07, Vol.10 (7), p.e0134839-e0134839

2015

Volltextzugriff (PDF)

Strong inducible knockdown of APC/CCdc20 does not cause mitotic arrest in human somatic cells

Cell cycle (Georgetown, Tex.), 2009-02, Vol.8 (4), p.643-646

2009

Volltextzugriff (PDF)

Effect of the interleukin‐6 C174G gene polymorphism on treatment of acute and chronic hepatitis C in human immunodeficiency virus coinfected patients

Hepatology (Baltimore, Md.), 2007-10, Vol.46 (4), p.1016-1025

2007

Volltextzugriff (PDF)

HCV reinfection incidence and spontaneous clearance rates in HIV-positive men who have sex with men in Western Europe

Journal of hepatology, 2017-02, Vol.66 (2), p.282-287

2017

Volltextzugriff (PDF)

Reinfection With the Hepatitis C Virus in Men Who Have Sex With Men After Successful Treatment With Direct-acting Antivirals in Germany: Current Incidence Rates, Compared With Rates During the Interferon Era

Clinical infectious diseases, 2020-08, Vol.71 (5), p.1248-1254

2020

Volltextzugriff (PDF)

Still trouble with bleeding: Risk factors for HCV transmission in men who have sex with men and behavioural trajectories from 2019 to 2021

HIV medicine, 2024-08, Vol.25 (8), p.976-989

2024

Volltextzugriff (PDF)

Bictegravir combined with emtricitabine and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection: week 96 results from a randomised, double-blind, multicentre, phase 3, non-inferiority trial

The lancet HIV, 2019-06, Vol.6 (6), p.e355-e363

2019

Volltextzugriff (PDF)

Recently acquired HCV infection in men who have sex with men in Germany in the direct‐acting antivirals era and during the COVID‐19 pandemic

HIV medicine, 2024-08, Vol.25 (8), p.967-975

2024

Volltextzugriff (PDF)

Molecular Analysis of Xenograft Models of Human Cancer Cachexia - Possibilities for Therapeutic Intervention

Cancer genomics & proteomics, 2007-05, Vol.4 (3), p.223-231

2007

Volltextzugriff (PDF)

Primary Resistance of Viruses in Reported New Cases of HIV, 2017-2020

Deutsches Ärzteblatt international, 2023-07, Vol.120 (27-28), p.479-480

2023

Volltextzugriff (PDF)

Sofosbuvir and Ledipasvir for 8 Weeks for the Treatment of Chronic Hepatitis C Virus (HCV) Infection in HCV-Monoinfected and HIV-HCV–Coinfected Individuals: Results From the German Hepatitis C Cohort (GECCO-01)

Clinical infectious diseases, 2016-11, Vol.63 (10), p.1320-1324

2016

Volltextzugriff (PDF)

Primary resistance of viruses in reported new cases of HIV, 2017–2020—findings of a nationwide molecular HIV surveillance program

Deutsches Ärzteblatt international, 2023-07, Vol.120 (27-28), p.479-480

2023

Volltextzugriff (PDF)

Glecaprevir/pibrentasvir in patients with chronic HCV and recent drug use: An integrated analysis of 7 phase III studies

Drug and alcohol dependence, 2019-01, Vol.194, p.487-494

2019

Volltextzugriff (PDF)

Eliminating Hepatitis C Virus Among Human Immunodeficiency Virus–Infected Men Who Have Sex With Men in Berlin: A Modeling Analysis

The Journal of infectious diseases, 2019-10, Vol.220 (10), p.1635-1644

2019

Volltextzugriff (PDF)

Is doxycycline post-exposure prophylaxis being utilised in Germany? Insights from an online survey among German men who have sex with men

Infection, 2024-07

2024

Volltextzugriff (PDF)

Functional Hypogonadism and Testosterone Deficiency in Aging Males With and Without HIV-infection

Experimental and clinical endocrinology & diabetes, 2021-11, Vol.129 (11), p.798

2021

Volltextzugriff (PDF)

Prevalence of patients with HIV receiving outpatient medical care in Germany-an analysis based on secondary data

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz, 2020-10, Vol.63 (10), p.1250-1261

2020

Volltextzugriff (PDF)

1 – 25 von 110

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(101)
Mit Volltextzugriff
(98)

Publikationsform

Sprache

Englisch
(96)
Deutsch
(15)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Long-Acting Cabotegravir and Rilpivirine for Maintenance of HIV-1 Suppression

Wie wirken Generikaquoten? Eine Analyse am Beispiel der HIV-Infektion

Häufigkeiten von Patienten mit HIV in der ambulanten Versorgung in Deutschland – Eine Analyse auf Basis von Sekundärdaten

Long-Acting Injectable Cabotegravir + Rilpivirine for HIV Maintenance Therapy: Week 48 Pooled Analysis of Phase 3 ATLAS and FLAIR Trials

Transmitted drug resistance and subtype patterns of viruses from reported new HIV diagnoses in Germany, 2017–2020

Effect of antiviral therapy for HCV on lipid levels

Real‐world effectiveness of sofosbuvir‐based treatment regimens for chronic hepatitis C genotype 3 infection: Results from the multicenter German hepatitis C cohort (GECCO‐03)

High effectiveness of recommended first-line antiretroviral therapies in Germany: a nationwide, prospective cohort study

Benefit of Treatment Individualization in Patients with Chronic Hepatitis C Receiving Peginterferon Alfa-2a and Ribavirin in a Large Noninterventional Cohort Study

Strong inducible knockdown of APC/CCdc20 does not cause mitotic arrest in human somatic cells

Effect of the interleukin‐6 C174G gene polymorphism on treatment of acute and chronic hepatitis C in human immunodeficiency virus coinfected patients

HCV reinfection incidence and spontaneous clearance rates in HIV-positive men who have sex with men in Western Europe

Reinfection With the Hepatitis C Virus in Men Who Have Sex With Men After Successful Treatment With Direct-acting Antivirals in Germany: Current Incidence Rates, Compared With Rates During the Interferon Era

Still trouble with bleeding: Risk factors for HCV transmission in men who have sex with men and behavioural trajectories from 2019 to 2021

Bictegravir combined with emtricitabine and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection: week 96 results from a randomised, double-blind, multicentre, phase 3, non-inferiority trial

Recently acquired HCV infection in men who have sex with men in Germany in the direct‐acting antivirals era and during the COVID‐19 pandemic

Molecular Analysis of Xenograft Models of Human Cancer Cachexia - Possibilities for Therapeutic Intervention

Primary Resistance of Viruses in Reported New Cases of HIV, 2017-2020

Sofosbuvir and Ledipasvir for 8 Weeks for the Treatment of Chronic Hepatitis C Virus (HCV) Infection in HCV-Monoinfected and HIV-HCV–Coinfected Individuals: Results From the German Hepatitis C Cohort (GECCO-01)

Primary resistance of viruses in reported new cases of HIV, 2017–2020—findings of a nationwide molecular HIV surveillance program

Glecaprevir/pibrentasvir in patients with chronic HCV and recent drug use: An integrated analysis of 7 phase III studies

Eliminating Hepatitis C Virus Among Human Immunodeficiency Virus–Infected Men Who Have Sex With Men in Berlin: A Modeling Analysis

Is doxycycline post-exposure prophylaxis being utilised in Germany? Insights from an online survey among German men who have sex with men

Functional Hypogonadism and Testosterone Deficiency in Aging Males With and Without HIV-infection

Prevalence of patients with HIV receiving outpatient medical care in Germany-an analysis based on secondary data

Suchergebnisse filtern